Link between aspirin, NSAIDs and colon cancer prevention may hinge on genetic variations

The link between taking aspirin, non-steroidal anti-inflammatory drugs, or NSAIDS, and colorectal cancer prevention is well established, but the mechanisms behind the protective effect have not been understood. A new study suggests this protection differs according to variations in DNA. (Mehr in: Cancer News — ScienceDaily)